Chester County News and Community Website
WARMINSTER, PA — Arbutus Biopharma Corporation (Nasdaq: ABUS) has announced promising new data from its IM-PROVE I Phase 2a clinical trial, suggesting significant advancements in treatment for chronic hepatitis B …
Arbutus Biopharma’s Clinical Trial Shows Promise for Hepatitis B Treatment Read More WARMINSTER, PA and OXFORD, United Kingdom — Arbutus Biopharma Corporation and Barinthus Biotherapeutics recently unveiled encouraging preliminary results from their Phase 2a IM-PROVE II clinical trial at the American Association …
Promising New Data from Hepatitis B Trial by Arbutus and Barinthus Read More WARMINSTER, PA — Arbutus Biopharma Corporation (Nasdaq: ABUS) will be participating in the H.C. Wainwright 5th Annual Viral Hepatitis Virtual Conference, scheduled for October 8, 2024. This event gathers industry experts …
Arbutus Biopharma to Present at H.C. Wainwright Viral Hepatitis Virtual Conference Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) has greenlit the marketing of a ground-breaking Hepatitis C virus (HCV) test, developed by Cepheid, marking a significant step in …
FDA Approves Revolutionary Hepatitis C Test: A Game Changer in Disease Diagnosis and Management Read More
PHILADELPHIA, PA — In a development that has prompted public health action, the Philadelphia Department of Public Health confirmed Friday that an employee at the ShopRite located at Oxford and …
Philadelphia Health Department Confirms Hepatitis A Case at Local ShopRite, Urges Vaccination Read More
The Department of Veterans Affairs (VA) has announced a fresh collaboration with the Global Liver Institute (GLI) to enhance the quality of life for Veterans diagnosed with liver diseases. Aimed …
Department of Veterans Affairs Partners with Global Liver Institute to Improve Veterans’ Liver Health Read More